Navigation Links
Align Technology Names Sheila Tan as VP, Marketing and Chief Marketing Officer
Date:3/12/2009

SANTA CLARA, Calif., March 12 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN), today announced that it has appointed Sheila Tan as vice president of marketing and chief marketing officer, effective immediately. Ms. Tan will report directly to Align President and Chief Executive Officer, Thomas M. Prescott.

"Sheila joined the Company in September 2008 as vice president of product innovation and marketing strategy and I'm pleased that she is taking on additional responsibility to lead our overall marketing organization," said Thomas M. Prescott, Align president and CEO. "Sheila's experience in consumer, oral care, and technology marketing will be of tremendous value to Align as we continue to execute our strategy to drive adoption of Invisalign."

Ms. Tan has over 16 years of experience creating brands, products, and marketing strategies in the consumer products, software, and Internet service industries. Her foundation in marketing comes from Procter & Gamble and Intuit, where she lead the development of new product concepts, launched new businesses, and managed the core marketing functions for Crest, Quicken.com, and QuickBooks.

More recently, Ms. Tan served as vice president, marketing for MokaFive, a leading provider of next generation desktop virtualization, targeting SMBs and enterprise IT. Prior to MokaFive, Ms. Tan was vice president, marketing at Presto Services, a unique digital-delivery service that enables families and friends to stay in touch via email, without the need for a computer or Internet connection.

Ms. Tan received her undergraduate degree in business from California Polytechnic State University, San Luis Obispo and her MBA from UCLA.

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998. Today, the Invisalign product family includes Invisalign, Invisalign Teen, Invisalign Assist, Invisalign Express, and Vivera Retainers.

To learn more about Invisalign or to find a certified Invisalign doctor in your area, please visit www.invisalign.com or call 1-800-INVISIBLE.

    Investor Relations Contact                    Press Contact
    Shirley Stacy                                 Shannon Mangum Henderson
    Align Technology, Inc.                        Ethos Communication, Inc.
    (408) 470-1150                                (678) 540-9222
    sstacy@aligntech.com                          align@ethoscommunication.com


'/>"/>
SOURCE Align Technology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Align Technology Executive to Present at Upcoming Financial Conferences
2. WellPoint Announces Realignment of Core Businesses; Names New Executives
3. Align Technology to Announce Third Quarter 2007 Financial Results on October 24, 2007
4. Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry
5. Test gives insight into prognosis in patients with plasma cell malignancies, finds Mayo Clinic study
6. Threshold Pharmaceuticals Announces Corporate Realignment
7. Early Results of Phase 2 Trial of Perifosine (KRX-0401) for the Treatment of Recurrent Malignant Gliomas Presented at the 12th Annual Scientific Meeting of Society for Neuro-Oncology
8. Dallas Among the First to Offer Probiotic Supplement Align(R)
9. McGill researchers link enzyme to breast cancer malignancy
10. Breast Cancer Genes Also Raise Mens Risk for Malignancy
11. iNOS expression may links chronic biliary inflammation to malignant transformation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... Utah (PRWEB) , ... April 21, 2017 , ... ... wilderness therapy treatment for adolescents and young adults, has kicked off its 4th ... April 23rd. This year’s theme is “Attachment Informed Therapy for Mental Health ...
(Date:4/21/2017)... ... , ... The Patient Advocacy Community of The Beryl Institute presented Eve DeVaro, ... Patient Advocacy Award in recognition of her extraordinary contributions to the field of ... The Beryl Institute’s annual Patient Experience Conference on March 20 in Denver, ...
(Date:4/21/2017)... ... ... Alive for Wellness is a group of clinical professionals and ... Alive team uses advanced behavioral sciences treatment modalities to accomplish their goals. ... struggle is based on 10 modalities of treatment that include: , ...
(Date:4/21/2017)... Ramon, CA (PRWEB) , ... April 21, 2017 , ... ... might not understand the estate planning process, or where to even begin. “Now more ... unresolved if you are to properly protect yourself and your family,” said attorney Lisa ...
(Date:4/21/2017)... GA (PRWEB) , ... April 21, 2017 , ... During ... in Augusta, Georgia. , This festival offers entertainment for everyone — from the ... Heart Garden Festival is a very high quality event held in a grand venue, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... MARLBOROUGH, Mass. , April 20, 2017 /PRNewswire/ ... company developing innovative therapeutics that address significant unmet ... new data from the Company,s consumer product development ... technology, at the Society for Investigative Dermatology (SID) ... is to advance and promote the sciences relevant ...
(Date:4/20/2017)... ZappRx, Inc ., a digital health company focused on modernizing ... closed $25 million in Series B funding led by Qiming ... Seattle that is part of a broader ... round included participation from SR One , who led ... (formerly Google Ventures). As part of the financing, Mark ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology: